Post-Transplant Diabetes Mellitus (PTDM) in Heart Recipients
Miroslaw GarlickiAnn Transplant 2005; 10(3): 51-53 :: ID: 496213
Abstract
Diabetes mellitus is a metabolic disorder that is prevalent in the general population, with more than one in five people over 50 years of age presenting with the condition [Van Hooff 2004].In general, (post-transplant) diabetes develops as a result of low or absent insulin output, increased insulin resistance, or a combination of the two. Transplant recipients generally take a combination of immunosuppressive drugs. Not only the calcineurin inhibitors cyclosporine and tacrolimus, but also corticosteroids have been associated with disturbances in glucose metabolic control [Van Dujinhoven 2003]. PTDM shares many similarities with type 2 diabetes and it may be reversible [Davidson et al. 2003]. The incidence of PTDM after heart transplantation is generally higher when compared to other organ transplantations [ISHLT 2004]....
Keywords: Post-Transplant
In Press
Case report
Tongue Carcinoma in Immunosuppressed Patients After Liver and Kidney Transplantation: A Case SeriesAnn Transplant In Press; DOI: 10.12659/AOT.951715
Original article
Prevalence and Risk Factors of Hepatic Steatosis in Kidney Transplant RecipientsAnn Transplant In Press; DOI: 10.12659/AOT.952251
Original article
The Anatomical Landscape of Living Donor Livers: A 101-Case Retrospective Single-Center Study in Indonesia ...Ann Transplant In Press; DOI: 10.12659/AOT.952031
Original article
Decreased Ventilation Duration and ICU Stay Associated With Early Percutaneous Dilatational Tracheostomy Af...Ann Transplant In Press; DOI: 10.12659/AOT.953143
Most Viewed Current Articles
24 Aug 2021 : Review article 20,545
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article 16,641
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
05 Apr 2022 : Original article 15,898
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 15,796
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988






